Zdrowie i gospodarka · 16/03/2004

FDA Publishes Guidance for Factor V Leiden DNA Mutation Detection Systems

The FDA has released a guidance document outlining the special controls for class II devices that detect the Factor V Leiden DNA mutation, which is now in effect and subject to public comment.